EDP Sciences logo
Submit your paper
Search
Menu
Home All issues Volume 18 / No 5 (Septembre-Octobre 2011) OCL, 18 5 (2011) 271-278 References
Open Access
Issue
OCL
Volume 18, Number 5, Septembre-Octobre 2011
Lipids and Brain II. Actes des Journées Chevreul 2011 (Deuxième partie)
Page(s) 271 - 278
Section PUFA and Neuroprotection
DOI https://doi.org/10.1051/ocl.2011.0389
Published online 15 September 2011
  • Allen CL, Bayraktutan U. Risk factors for ischaemic stroke. Int J Stroke 2008; 3: 105–16. [CrossRef] [PubMed] [Google Scholar]
  • Bas O, Songur A, Sahin O, et al. The protective effect of fish n-3 fatty acids on cerebral ischemia in rat hippocampus. Neurochem Int 2007; 50: 548–54. [CrossRef] [PubMed] [Google Scholar]
  • Blondeau N, Lauritzen I, Widmann C, Lazdunski M, Heurteaux C. A potent protective role of lysophospholipids against global cerebral ischemia and glutamate excitotoxicity in neuronal cultures. J Cereb Blood Flow Metab 2002a; 22: 821–34. [Google Scholar]
  • Blondeau N, Nguemeni C, Debruyne DN, et al. Subchronic alpha-linolenic acid treatment enhances brain plasticity and exerts an antidepressant effect: a versatile potential therapy for stroke. Neuropsychopharmacology 2009; 34: 2548–59. [CrossRef] [PubMed] [Google Scholar]
  • Blondeau N, Petrault O, Manta S, et al. Polyunsaturated fatty acids are cerebral vasodilators via the TREK-1 potassium channel. Circ Res 2007; 101: 176–84. [CrossRef] [PubMed] [Google Scholar]
  • Blondeau N, Plamondon H, Richelme C, Heurteaux C, Lazdunski M. K(ATP) channel openers, adenosine agonists and epileptic preconditioning are stress signals inducing hippocampal neuroprotection. Neuroscience 2000; 100: 465–74. [CrossRef] [PubMed] [Google Scholar]
  • Blondeau N, Widmann C, Lazdunski M, Heurteaux C. Activation of the nuclear factor-kappaB is a key event in brain tolerance. J Neurosci 2001; 21: 4668–77. [PubMed] [Google Scholar]
  • Blondeau N, Widmann C, Lazdunski M, Heurteaux C. Polyunsaturated fatty acids induce ischemic and epileptic tolerance. Neuroscience 2002b; 109: 231–41. [Google Scholar]
  • Dauchet L, Amouyel P, Dallongeville J. Fruit and vegetable consumption and risk of stroke: a meta-analysis of cohort studies. Neurology 2005; 65: 1193–7. [CrossRef] [PubMed] [Google Scholar]
  • de Goede J, Verschuren WM, Boer JM, Kromhout D, Geleijnse JM. Alpha-linolenic Acid intake and 10-year incidence of coronary heart disease and stroke in 20,000 middle-aged men and women in the Netherlands. PLoS One 2011; 6: e17967. [CrossRef] [PubMed] [Google Scholar]
  • Dirnagl U, Simon RP, Hallenbeck JM. Ischemic tolerance and endogenous neuroprotection. Trends Neurosci 2003; 26: 248–54. [CrossRef] [PubMed] [Google Scholar]
  • Endres M, Dirnagl U. Ischemia and stroke. Adv Exp Med Biol 2002; 513: 455–73. [CrossRef] [PubMed] [Google Scholar]
  • Fink M, Lesage F, Duprat F, et al. A neuronal two P domain K+ channel stimulated by arachidonic acid and polyunsaturated fatty acids. EMBO J 1998; 17: 3297–308. [CrossRef] [PubMed] [Google Scholar]
  • Gidday JM. Cerebral preconditioning and ischaemic tolerance. Nat Rev Neurosci 2006; 7: 437–48. [CrossRef] [PubMed] [Google Scholar]
  • Heurteaux C, Laigle C, Blondeau N, Jarretou G, Lazdunski M. Alpha-linolenic acid and riluzole treatment confer cerebral protection and improve survival after focal brain ischemia. Neuroscience 2006; 137: 241–51. [CrossRef] [PubMed] [Google Scholar]
  • Iadecola C. Neurovascular regulation in the normal brain and in Alzheimer’s disease. Nat Rev Neurosci 2004; 5: 347–60. [CrossRef] [PubMed] [Google Scholar]
  • Jonas S, Ayigari V, Viera D, Waterman P. Neuroprotection against cerebral ischemia. A review of animal studies and correlation with human trial results. Ann N Y Acad Sci 1999; 890: 2–3. [CrossRef] [PubMed] [Google Scholar]
  • Kirino T. Ischemic tolerance. J Cereb Blood Flow Metab 2002; 22: 1283–96. [CrossRef] [PubMed] [Google Scholar]
  • Kitagawa K, Matsumoto M, Tagaya M, et al. ‘Ischemic tolerance’ phenomenon found in the brain. Brain Res 1990; 528: 21–4. [CrossRef] [PubMed] [Google Scholar]
  • Lauritzen I, Blondeau N, Heurteaux C, Widmann C, Romey G, Lazdunski M. Polyunsaturated fatty acids are potent neuroprotectors. EMBO J 2000; 19: 1784–93. [CrossRef] [PubMed] [Google Scholar]
  • Lloyd-Jones D, Adams RJ, Brown TM, et al. Heart disease and stroke statistics–2010 update: a report from the American Heart Association. Circulation 2010; 121: e46–e215. [CrossRef] [PubMed] [Google Scholar]
  • Lo EH. Experimental models, neurovascular mechanisms and translational issues in stroke research. Br J Pharmacol 2008; 153 (Suppl. 1): S396–405. [CrossRef] [PubMed] [Google Scholar]
  • Lo EH, Rosenberg GA. The neurovascular unit in health and disease: introduction. Stroke 2009; 40: S2–3. [CrossRef] [PubMed] [Google Scholar]
  • Minnerup J, Schabitz WR. Multifunctional actions of approved and candidate stroke drugs. Neurotherapeutics 2009; 6: 43–52. [CrossRef] [PubMed] [Google Scholar]
  • Moskowitz MA, Lo EH, Iadecola C. The science of stroke: mechanisms in search of treatments. Neuron 2010; 67: 181–98. [CrossRef] [PubMed] [Google Scholar]
  • Nguemeni C, Delplanque B, Rovere C, et al. Dietary supplementation of alpha-linolenic acid in an enriched rapeseed oil diet protects from stroke. Pharmacol Res 2010; 61: 226–33. [CrossRef] [PubMed] [Google Scholar]
  • O’Duffy AE, Bordelon YM, McLaughlin B. Killer proteases and little strokes–how the things that do not kill you make you stronger. J Cereb Blood Flow Metab 2007; 27: 655–68. [PubMed] [Google Scholar]
  • Obrenovitch TP. Molecular physiology of preconditioning-induced brain tolerance to ischemia. Physiol Rev 2008; 88: 211–47. [CrossRef] [PubMed] [Google Scholar]
  • Ozen OA, Cosar M, Sahin O, et al. The protective effect of fish n-3 fatty acids on cerebral ischemia in rat prefrontal cortex. Neurol Sci 2008; 29: 147–52. [CrossRef] [PubMed] [Google Scholar]
  • Plamondon H, Blondeau N, Heurteaux C, Lazdunski M. Mutually protective actions of kainic acid epileptic preconditioning and sublethal global ischemia on hippocampal neuronal death: involvement of adenosine A1 receptors and K(ATP) channels. J Cereb Blood Flow Metab 1999; 19: 1296–308. [CrossRef] [PubMed] [Google Scholar]
  • Pulsinelli WA, Brierley JB. A new model of bilateral hemispheric ischemia in the unanesthetized rat. Stroke 1979; 10: 267–72. [CrossRef] [PubMed] [Google Scholar]
  • Relton JK, Strijbos PJ, Cooper AL, Rothwell NJ. Dietary N-3 fatty acids inhibit ischaemic and excitotoxic brain damage in the rat. Brain Res Bull 1993; 32: 223–6. [CrossRef] [PubMed] [Google Scholar]
  • Riediger ND, Othman RA, Suh M, Moghadasian MH. A systemic review of the roles of n-3 fatty acids in health and disease. J Am Diet Assoc 2009; 109: 668–79. [CrossRef] [PubMed] [Google Scholar]
  • Rosamond W, Flegal K, Furie K, et al. Heart disease and stroke statistics–2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2008; 117: e25–146. [CrossRef] [PubMed] [Google Scholar]
  • Simopoulos AP. The importance of the omega-6/omega-3 fatty acid ratio in cardiovascular disease and other chronic diseases. Exp Biol Med (Maywood) 2008; 233: 674–88. [CrossRef] [PubMed] [Google Scholar]
  • Tauskela JS, Blondeau N 2009 In: Ischemic Tolerance of the Brain, Research Signpost. Schaller BJ, Ed.; Kerala, India: Research Signpost, 2009: 85–135. [Google Scholar]
  • Weih M, Kallenberg K, Bergk A, et al. Attenuated stroke severity after prodromal TIA: a role for ischemic tolerance in the brain? stroke 1999; 30: 1851–4. [CrossRef] [PubMed] [Google Scholar]
  • Zaleska MM, Mercado ML, Chavez J, Feuerstein GZ, Pangalos MN, Wood A. The development of stroke therapeutics: promising mechanisms and translational challenges. Neuropharmacology 2009; 56: 329–41. [CrossRef] [PubMed] [Google Scholar]
  • Zhang ZG, Chopp M. Neurorestorative therapies for stroke: underlying mechanisms and translation to the clinic. Lancet Neurol 2009; 8: 491–500. [CrossRef] [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.